| A02AD - Combinations and Complexes Of Aluminium, Calcium and Magnesium Compounds | ATC-DDD Version 2016. Source: WHO | | A - Alimentary Tract and Metabolism | | |
| | A02 - Drugs for Acid Related Disorders | | |
| | A02A - Antacids | This group comprises plain antacid drugs, antacids in combination with antiflatulents and antacids in combination with other drugs.
Antacids in combination with liquorice root or linseed are classified in this group.
Plain antiflatulents, see A03AX - Other drugs for functional gastrointestinal disorders.
| The DDDs for antacids are based on treatment of hyperacidity and dyspepsia, not ulcus. One exception, however, is antacids in combination with antispasmodics in A02AG, where the DDDs are based on treatment of ulcus.
For ordinary salt combinations in A02AD, fixed doses are used instead of individual doses for every single preparation (10 tablets = 10 UD; 50 ml mixture = 10 UD).
|
| | A02AD - Combinations and Complexes Of Aluminium, Calcium and Magnesium Compounds | Antacids with two or more of the substances in combination are classified here.
Ordinary salt combinations are classified at the same 5th level A02AD01 e.g. combinations of aluminium hydroxide, magnesium carbonate gel and attapulgite, while the various complexes with a layer structure are classified at separate 5th levels e.g. magaldrate and almagate.
|
|
|
|
